🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for revolutionary findings that illuminate how the body's defense network attacks dangerous pathogens while sparing the body's own cells.

A trio of renowned researchers—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—share this honor.

Their work uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells capable of harming the body.

The findings are now paving the way for innovative therapies for immune disorders and cancer.

The laureates will share a monetary award valued at 11m Swedish kronor.

Crucial Findings

"The work has been decisive for understanding how the body's defenses functions and the reason we do not all develop severe self-attack conditions," commented the chair of the award panel.

This trio's research explain a core mystery: In what way does the defense system defend us from countless invaders while keeping our healthy cells unharmed?

The immune system uses immune cells that search for signs of infection, even pathogens and germs it has not met before.

These defenders utilize sensors—known as receptors—that are produced by chance in countless combinations.

This provides the immune system the ability to combat a wide array of threats, but the unpredictability of the mechanism inevitably creates white blood cells that may target the body.

Protectors of the Immune System

Scientists previously understood that a portion of these problematic white blood cells were destroyed in the thymus—where immune cells mature.

The latest award honors the discovery of T-reg cells—described as the body's "peacekeepers"—which patrol the system to neutralize any defenders that assault the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel stated, "The findings have established a new field of investigation and accelerated the creation of new therapies, for example for cancer and immune disorders."

In malignancies, T-regs prevent the body from attacking the tumor, so studies are aimed at lowering their quantity.

In self-attack disorders, trials are testing boosting T-reg cells so the body is no longer being harmed. A comparable method could also be useful in reducing the chances of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, from a Japanese institution, conducted experiments on mice that had their immune gland extracted, causing self-attack conditions.

He demonstrated that injecting defense cells from healthy animals could stop the illness—implying there was a mechanism for preventing defenders from attacking the host.

Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic immune disorder in rodents and humans that resulted in the identification of a genetic factor vital for how regulatory T-cells function.

"The groundbreaking research has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," commented a prominent physiology expert.

"The work is a remarkable example of how basic physiological research can have far-reaching consequences for public health."